<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre=": Review: Review Hypothetical targets and plausible drugs of coronavirus" exact="infection" post="caused by SARSâ€�CoVâ€�2 ALMASI and MOHAMMADIPANAH AlmasiFaezeh1MohammadipanahFatemehhttps://orcid.org/0000-0003-0286-53421fmohammadipanah@ut.ac.ir[1], Pharmaceutical Biotechnology"/>
 <result pre="drug discovery are suggested. Emphasizing the potential route of SARSâ€�CoVâ€�2" exact="infection" post="and virus entryâ€�related factors like integrins, cathepsin and ACE2"/>
 <result pre="word-count: AlmasiF, MohammadipanahF. Hypothetical targets and plausible drugs of coronavirus" exact="infection" post="caused by SARS-CoV-2. Transbound Emerg Dis. 2020;00:1â€&quot;15. 10.1111/tbed.13734 1"/>
 <result pre="drug for SARSâ€�CoVâ€�2. These three approaches lead to the potential" exact="treatment" post="options including the drug repurposing, screening molecular databases using"/>
 <result pre="lead to the potential treatment options including the drug repurposing," exact="screening" post="molecular databases using drug design tools and screening the"/>
 <result pre="drug repurposing, screening molecular databases using drug design tools and" exact="screening" post="the compound libraries in antiâ€�viral assays. By the time"/>
 <result pre="the compounds chloroquine (CQ) and remdesivir (RDV) effectively inhibited the" exact="infection" post="by SARSâ€�CoVâ€�2 with a high selectivity index at low"/>
 <result pre="the clinical trial phase III for the purpose of viral" exact="infection" post="control caused by the Ebola virus. The remdesivir is"/>
 <result pre="assess the use of antiâ€�viral drug candidate for the potential" exact="treatment" post="of SARSâ€�CoVâ€�2 by Gilead Sciences. All reported potential drug"/>
 <result pre="diseases using the natalizumab antibody (Î±4Î²1/Î²7 integrin inhibitor) and the" exact="treatment" post="of acute coronary syndrome with the small molecule tirofiban"/>
 <result pre="on the integrin inhibition, highlighting the impact of integrin in" exact="treatment" post="of various diseases (Ley, Riveraâ€�Nieves, Sandborn, &amp;amp; Shattil,Â 2016)."/>
 <result pre="It was shown that the approved blockers can impair the" exact="infection" post="of major HCV variants in in vitro and in"/>
 <result pre="(A9) as a competent blocker of transmissible gastroenteritis virus (TGEV)" exact="infection" post="belong to Alphacoronavirus genera as a successor model for"/>
 <result pre="introduced a lipopeptide named EK1C4 that effectively block the SARSâ€�CoVâ€�2" exact="infection" post="in in vitro experiments with IC50 of 36.5Â nM"/>
 <result pre="nsp3 releases proteins involved in both replication of coronavirus and" exact="infection" post="processes. In addition to the LXGG motif found inâ€�between"/>
 <result pre="can be an attractive target for the intervention in the" exact="infection" post="progress. RNAâ€�dependent RNA polymerase (RdRp) (nsp12) or RNA replicase"/>
 <result pre="proofreading activity, identifying nucleoside analogue inhibitors hold promise for the" exact="treatment" post="of SARSâ€�CoVâ€�2. 3.5 Viral protein assembly Capsid proteins have"/>
 <result pre="for researches towards developing the new therapeutic agents for CoV" exact="infection" post="(Qin, Zhao, Cao, &amp;amp; Qi,Â 2007). The inhibition of"/>
 <result pre="using the existing antiâ€�viral compounds. Therefore, in silico or practical" exact="screening" post="of molecular targets is being conducted on structural information"/>
 <result pre="combating cocktail. Six clinical trials are currently underway to specify" exact="testing" post="remdesivir with other medicines, according to Informa Pharma Intelligence."/>
 <result pre="and rigorous process of drug discovery, highâ€�throughput methods and highâ€�content" exact="screening" post="methods can be employed. However, by the immediate global"/>
 <result pre="the immediate global need for drugs to control the SARSâ€�CoVâ€�2" exact="infection" post="drug search is currently pursued by the repurposing approach."/>
 <result pre="&amp;amp; Di Napoli, R. (2020, April 6). Features, evaluation and" exact="treatment" post="coronavirus (COVIDâ€�19) [in StatPearls]. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK554776/ Chan, J.â€�F.â€�W.,"/>
 <result pre="Journal of Cancer, 117, 59â€&quot;67. 10.1002/ijc.2115315880533 Contini, A. (2020). Virtual" exact="screening" post="of an FDA approved drugs database on two COVIDâ€�19"/>
 <result pre="inhibits MERSâ€�and SARSâ€�coronavirus replication in cell culture, but not SARSâ€�coronavirus" exact="infection" post="in a mouse model. Virus Research, 228, 7â€&quot;13. 10.1016/j.virusres.2016.11.01127840112"/>
 <result pre="the toolbox: Receptor tyrosine kinases as potential targets in the" exact="treatment" post="of hepatitis C. Journal of Hepatology, 56, 282â€&quot;284. 10.1016/j.jhep.2011.06.02021784050"/>
 <result pre="Mak, A., Yan, Y., &amp;amp; Zhu, Y. (2020). Novel coronavirus" exact="treatment" post="with ribavirin: Groundwork for evaluation concerning COVIDâ€�19. Journal of"/>
 <result pre="J., &amp;amp; Denison, M. R. (2019). Nucleoside analogues for the" exact="treatment" post="of coronavirus infections. Current Opinion in Virology, 35, 57â€&quot;62."/>
 <result pre="O., Phelan, A., â€¦ Stebbing, J. (2020). Baricitinib as potential" exact="treatment" post="for 2019â€�nCoV acute respiratory disease. Lancet, 395, e3010.1016/S0140-6736(20)30304-432032529 Rosa,"/>
 <result pre="Berline, J. W., &amp;amp; Palefsky, J. M. (2003). Epsteinâ€�Barr virus" exact="infection" post="of polarized tongue and nasopharyngeal epithelial cells. Nature Medicine,"/>
 <result pre="C., Herzog, N. K., &amp;amp; Aronson, J. F. (2008). Genistein" exact="treatment" post="of cells inhibits arenavirus infection. Antiviral Research, 77, 153â€&quot;156."/>
 <result pre="281â€&quot;292. 10.1016/j.cell.2020.02.05832155444 Wang, J. (2020). Fast identification of possible drug" exact="treatment" post="of coronavirus diseaseâ€�19 (COVIDâ€�19) through computational drug repurposing study."/>
 <result pre="Q., Feng, S., â€¦ Liu, S. (2020). Inhibition of SARSâ€�CoVâ€�2" exact="infection" post="(previously 2019â€�nCoVSARSâ€�COVâ€�2) by a highly potent panâ€�coronavirus fusion inhibitor"/>
 <result pre="Long, J., Zhong, Y., &amp;amp; Li, Y. (2020). The epidemiology," exact="diagnosis" post="and treatment of COVIDâ€�19. International Journal of Antimicrobial Agents,"/>
 <result pre="Zhong, Y., &amp;amp; Li, Y. (2020). The epidemiology, diagnosis and" exact="treatment" post="of COVIDâ€�19. International Journal of Antimicrobial Agents, 55, 10595510.1016/j.ijantimicag.2020.10595532234468"/>
</results>
